Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial

Lacroix, A; Gu, F; Gallardo, W; Pivonello, R; Yu, YR; Witek, P; Boscaro, M; Salvatori, R; Yamada, M; Tauchmanova, L; Roughton, M; Ravichandran, S; Petersenn, S; Biller, BMK; Newell-Price, J

Lacroix, A (reprint author), Ctr Hosp Univ Montreal, Montreal, PQ H2W 1T8, Canada.

LANCET DIABETES & ENDOCRINOLOGY, 2018; 6 (1): 17

Abstract

Background Cushing's disease is a rare debilitating endocrine disorder for which few prospective interventional studies have been done. We report resu......

Full Text Link